Results 161 to 170 of about 2,229,234 (312)

Bringing Gene Therapy Into Real World Clinical Practice

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach   +2 more
wiley   +1 more source

Patterns of multimodal MRD response and toxicity with blinatumomab and tyrosine kinase inhibitors in Philadelphia‐positive acute B‐lymphoblastic leukaemia

open access: yes
British Journal of Haematology, EarlyView.
Sebastian M. Stolz   +6 more
wiley   +1 more source

Italian Patients Journey for Gene Therapy in Haemophilia A

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Gene therapy (GT) provides sustained FVIII levels without repeated infusions in Hemophilia A (HA) patients thus overcoming a major limitation of replacement therapy. However, issues remain e.g., patient selection criteria, duration and variability of transgene expression, quality of life and long‐term safety.
Giovanni Di Minno   +19 more
wiley   +1 more source

Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)

open access: yes
British Journal of Haematology, EarlyView.
Miles Thomas   +6 more
wiley   +1 more source

Cutaneous involvement by myeloid leukaemias: challenging cases with important implications

open access: yesHistopathology, EarlyView.
Myeloid leukaemias and precursors involving the skin are often challenging to diagnose with varied and overlapping clinical and histopathologic features. Nonetheless, they are critical for pathologists to recognize and accurately classify. This review discusses the clinical, histopathological and genetic features of myelodysplasia cutis (A) and ...
Alexandra C. Hristov
wiley   +1 more source

ICSH Guidance on Bone Marrow Examination and Reporting

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Examination of the bone marrow (BM) remains fundamental to the diagnosis, classification, prognostication, and monitoring of hematolymphoid and other disorders affecting blood cell production. Since publication of the International Council for Standardization in Haematology (ICSH) guideline in 2008, advances in diagnostic technologies, disease
Wendy N. Erber   +6 more
wiley   +1 more source

Optimization of Leukocytic Flags in the Sysmex‐XN Series With the Help of Flow Cytometric Differential (FlowDiff) Can Significantly Optimize Laboratory Efficiency

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Objectives The aim of this study was to adjust the default white blood cell (WBC) differential count flag settings on the Sysmex XN‐9100 haematology analyser to reduce unnecessary additional leukocyte differential counts without compromising diagnostic sensitivity.
Ninna Hahn Tougaard   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy